Stockscreener 앱 받기
23.55
0.04%
0.01
시간 외 거래:
23.02
-0.53
-2.25%
전일 마감가:
$23.54
열려 있는:
$23.87
하루 거래량:
5.17M
Relative Volume:
1.08
시가총액:
$11.77B
수익:
$4.89B
순이익/손실:
$-242.00M
주가수익비율:
-48.16
EPS:
-0.489
순현금흐름:
$315.00M
1주 성능:
+2.75%
1개월 성능:
+3.02%
6개월 성능:
+1.82%
1년 성능:
+14.77%
1일 변동 폭
$23.41
$24.11
1주일 범위
$22.22
$24.11
52주 변동 폭
$19.40
$27.98
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
23.55 | 11.77B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2025-10-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Deferring cash fees, Elanco (ELAN) director Kapila K. Anand acquires 642 stock-linked units. - stocktitan.net
Elanco Animal Health CEO Jeffrey N. Simmons Reports Acquisition of Deferred Stock Units - Kalkine Media
Form 4 Elanco Animal Health For: 22 September By Investing.com - Investing.com Nigeria
Form 4 Elanco Animal Health For: 22 September By Investing.com - Investing.com Canada
Elanco Animal Health (ELAN) CEO adds 126 deferred stock units - Stock Titan
Elanco (NYSE: ELAN) exec adds 65.8756 deferred stock units - Stock Titan
Elanco (NYSE: ELAN) CFO now holds 158.6535 deferred stock units - Stock Titan
Elanco Animal Health Incorporated (ELAN) Latest Press Releases & Corporate News - finance.yahoo.com
Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement - Yahoo Finance
Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - PR Newswire
Elanco Animal Health (ELAN) CFO receives 8 deferred stock units - Stock Titan
Deferred stock award lifts Elanco Animal Health (NYSE: ELAN) exec's holdings - Stock Titan
Elanco (NYSE: ELAN) CEO adds to deferred pay with new stock grant - Stock Titan
Elanco Animal Health (ELAN) 10K Form and Latest SEC Filings 2026 - MarketBeat
Mutts With a Mission: How Elanco and Medical Mutts Transform Lives Together - CSRwire
Elanco Animal Health Stock Price Forecast. Should You Buy ELAN? - StockInvest.us
Elanco Director Purchases 40,000 Shares for $936,000 - Yahoo Finance
Elanco Director Purchases 40,000 Shares for $936,000 - The Motley Fool
Elanco Animal Health Inc (ELAN) Stock Price, Quote, News & History - Benzinga
Is Elanco Animal Health Inc (ELAN) Overvalued After 3.2% Rally? - GuruFocus
Pharma clinical research firm eyes former Elanco building in Greenfield - Indianapolis Business Journal
Elanco Animal Health (ELAN) Institutional Ownership 2026 $ELAN - MarketBeat
Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility - marketscreener.com
Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility - finance.yahoo.com
Elanco Animal Health (ELAN) Stock Analysis: Unveiling a 29% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews
Elanco Says Demand for Its New Dog Treatment Is Twice What Was Expected - Stock Titan
Elanco (NYSE: ELAN) EVP now holds 9,770 deferred units - Stock Titan
Elanco Animal Health CEO Jeffrey N. Simmons Acquires 117.94 Deferred Stock Units - kalkinemedia.com
Elanco (NYSE: ELAN) reports new insider share trade - Stock Titan
Elanco (NYSE: ELAN) CFO holds 141.8242 deferred stock units - Stock Titan
Elanco Animal Health CFO Robert M. VanHimbergen Acquires 8.22 Deferred Stock Units - Kalkine Media
US Insider Trades Show Shifts In Key Names - TradingPedia
Top insider buys and sells disclosed on Friday - Investing.com
Top insider buys and sells disclosed on Friday By Investing.com - Investing.com South Africa
Elanco Animal Health (ELAN) Stock Analysis: Unlocking a 30% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
Elanco Animal Health (NYSE:ELAN) Director Lawrence Erik Kurzius Purchases 40,000 Shares - MarketBeat
Elanco director Kurzius buys $935,920 in company stock - Investing.com
Elanco director Kurzius buys $935,920 in company stock - Investing.com
Elanco Animal Health Director Purchased Shares Worth Over $935K - TradingView
Elanco (NYSE: ELAN) director buys 40K shares, stake now 188,647 - Stock Titan
Danske Bank A S Makes New $14.35 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Shares Fall 3.8% -- What GF Scor - GuruFocus
Stifel reiterates Buy rating on Elanco stock, $33 target By Investing.com - Investing.com Canada
245,707 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Great Lakes Advisors LLC - MarketBeat
Elanco Animal Health: New Products To Support Growth (NYSE:ELAN) - Seeking Alpha
Attention investors: You may be eligible for a $15 million Elanco Animal Health SEC fair fund payment - Claim Depot
Elanco Animal Health (NYSE:ELAN): Is More Momentum Ahead? - Kalkine Media
CNBC Final Trades: Netflix, Eli Lilly, Elanco Animal Health & MoreNetflix (NASDAQ:NFLX), Eli Lilly (NY - Benzinga
160,631 Shares in Elanco Animal Health Incorporated $ELAN Purchased by First National Bank of Omaha - MarketBeat
Director's Confidence Visible as Elanco Leader Buys 10,000 Shares - Yahoo Finance
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엘란코 주식 (ELAN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | Director |
Aug 20 '26 |
Buy |
23.40 |
40,000 |
935,920 |
188,647 |
| O'Neill Shiv | GC AND CORP SEC |
Aug 18 '26 |
Buy |
23.58 |
3,998 |
94,273 |
87,832 |
| Harrington Michael J | Director |
Aug 12 '26 |
Buy |
21.82 |
5,000 |
109,100 |
131,451 |
| Herendeen Paul | Director |
Aug 07 '26 |
Buy |
23.68 |
10,000 |
236,850 |
111,687 |
| VanHimbergen Robert M | EVP and CFO |
Aug 07 '26 |
Buy |
23.08 |
4,200 |
96,926 |
137,516 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
May 15 '26 |
Buy |
20.09 |
4,971 |
99,843 |
171,971 |
| Modi Rajeev A. | SEE REMARKS |
May 15 '26 |
Buy |
20.35 |
4,911 |
99,939 |
160,812 |
| Kurzius Lawrence Erik | Director |
Dec 12 '25 |
Buy |
21.30 |
10,000 |
213,000 |
131,773 |
| Modi Rajeev A. | SEE REMARKS |
Dec 11 '25 |
Buy |
21.33 |
4,500 |
95,985 |
123,082 |
| VanHimbergen Robert M | EVP and CFO |
Dec 11 '25 |
Buy |
21.64 |
6,950 |
150,426 |
124,233 |
1.32%
0.91%
자본화:
|
볼륨(24시간):